Frances E. Boxall
50 works · 4,492 citations · h-index 18
Top works
- Carboplatin dosage: prospective evaluation of a simple formula based on renal function.
- Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation
- The comparative pharmacokinetics of carboplatin and cisplatin in mice and rats
- Flameless atomic absorption spectrophotometric determination of platinum in tissues solubilized in hyamine hydroxide
- NVP-AUY922: A Novel Heat Shock Protein 90 Inhibitor Active against Xenograft Tumor Growth, Angiogenesis, and Metastasis
- Plasma free platinum pharmacokinetics in patients treated with high dose carboplatin
- A phase I and pharmacology study of an oral platinum complex, JM216: dose-dependent pharmacokinetics with single-dose administration
- cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
- Comparative distribution and excretion of carboplatin and cisplatin in mice
- Carboplatin dosage: prospective evaluation of a simple formula based on renal function.
- BCL-2 family protein expression and platinum drug resistance in ovarian carcinoma
- Schedule dependency of orally administered bis-acetato-ammine-dichloro-cyclohexylamine-platinum(IV) (JM216) in vivo.
- Mechanisms of drug resistance to the platinum complex ZD0473 in ovarian cancer cell lines
- Biliary Excretion, Renal Handling and Red Cell Uptake of Cisplatin and CBDCA in Animals
- Pharmacokinetics of cis-diammine-1,1-cyclobutane dicarboxylate platinum II (CBDCA, JM8) in mice and rats
- Metabolism, protein binding and in vivo activity of the oral platinum drug JM216 and its biotransformation products.
- Sequence-dependent synergism between the new generation platinum agent ZD0473 and paclitaxel in cisplatin-sensitive and -resistant human ovarian carcinoma cell lines
- Antitumor and Cellular Pharmacological Properties of a Novel Platinum(IV) Complex:trans-[PtCl2(OH)2(Dimethylamine) (Isopropylamine)]
- The myelotoxicity of carboplatin is influenced by the time of its administration
- The effect of diethyldithiocarbamate on the haematological toxicity and antitumour activity of carboplatin